NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Delcath System, the Company’s percutaneous hepatic perfusion (“PHP”) technology, is being highlighted in oral discussions and a poster presentation at several prominent scientific meetings taking place during the first quarter of 2008, increasing the technology’s exposure within the medical and scientific communities.
